Gastrointestinal Symptoms in Obesity Therapy: Mechanisms, Epidemiology, and Management Strategies
Obesity management, whether lifestyle-based, pharmacological, or surgical, is frequently associated with gastrointestinal adverse effects (GI AEs) that may impact treatment adherence and patient quality of life. With the increasing use of incretin-based anti-obesity medications (AOMs), they have gai...
Zapisane w:
| Główni autorzy: | , , , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
MDPI AG
2025-09-01
|
| Seria: | Biomedicines |
| Hasła przedmiotowe: | |
| Dostęp online: | https://www.mdpi.com/2227-9059/13/10/2362 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|